Revolution Medicines, Inc. · NASDAQ:RVMD
Anders Jack sold 4,053 Revolution Medicines, Inc. shares (Form 4)
Traded Sep 16, 2026 · Filed Sep 18, 2026
On Sep 16, 2026, Anders Jack (Chief Financial Officer) sold 4,053 Revolution Medicines, Inc. shares at an average US$199.24 for US$808K under a trading plan, leaving 119,216 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 4,053 shares
- Price
- US$199.24 average (US$195.00 to US$199.30)
- Value
- US$808K
- Holding after
- 119,216 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | Sale | 61 | US$195.00 | 123,208 | Direct |
| Sep 16, 2026 | Common Stock | Sale | 3,992 | US$199.30 | 119,216 | Direct |
Source
Related
- Revolution Medicines, Inc.
- Anders Jack
- Revolution Medicines, Inc. shareholders
- Form 4 · Anders Jack · Nov 13, 2026
- Form 4 · Anders Jack · Jun 26, 2026
- Form 4 · Anders Jack · Jun 18, 2026
- Form 4 · Kelsey Stephen Michael · Nov 18, 2026
- Form 4 · Borellini Flavia · Nov 17, 2026
- Schedule 13G/A · Baker Bros. Advisors LP · Nov 16, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Form 4 · Borisy Alexis · Nov 13, 2026